What the reflex buys in the short term
Within seconds, sympathetic activation raises cardiac output through two direct cardiac effects and supports it through two vascular effects. Increased heart rate raises output because cardiac output equals heart rate multiplied by stroke volume. Increased contractility raises stroke volume by shifting the ventricle to a higher inotropic state, so it ejects more at any given filling pressure. Venoconstriction reduces venous capacitance, which maintains venous return and therefore preload. Arteriolar constriction raises systemic vascular resistance, which helps sustain arterial pressure and redistributes blood toward the heart and brain. Together these effects can restore arterial pressure and perfusion before any hormonal response has time to develop.
The same signal raises the load
Arteriolar constriction is not selective. The rise in systemic vascular resistance that supports blood pressure is also a rise in afterload — the resistance the ventricle must overcome to eject. For a failing ventricle with reduced contractility, a higher afterload directly reduces stroke volume, partially cancelling the benefit of increased contractility. The heart is therefore asked to contract harder against a greater resistance, which raises myocardial oxygen demand at the same time that coronary perfusion may be limited. This is the central paradox of sympathetic compensation: the mechanism that defends output also increases the work required to produce it.
Costs that accumulate with sustained activation
- Increased myocardial oxygen demand from faster rate and stronger contraction, which can outstrip coronary supply and provoke ischemia.
- Arrhythmia risk: sympathetic stimulation of the myocardium lowers the threshold for ventricular ectopy and tachyarrhythmias, and a fast rate itself can be poorly tolerated by a failing ventricle.
- Redistribution of blood flow away from skin, splanchnic beds, and skeletal muscle, which over time contributes to fatigue, poor exercise tolerance, and renal hypoperfusion.
- Direct myocyte toxicity: sustained catecholamine exposure has adverse effects on cardiac myocytes, contributing to further functional decline.
Why the benefit fades
Chronic exposure to high catecholamine levels downregulates beta-adrenergic receptors on cardiac myocytes and uncouples them from their signaling pathway. The heart becomes less responsive to sympathetic stimulation, so the inotropic and chronotropic benefit diminishes over time. The vascular and metabolic costs, however, do not fade in parallel, because they are mediated through different receptors and mechanisms. The net result is a compensation that is most effective when it is needed least — early and briefly — and least effective when it is needed most — late and continuously.